CorMedix CRMD
NASDAQ CRMD
$7.79 +0.22 (+2.91%)
At close: Oct 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) EV to EBIT (2025 - 2026)

Updated

CorMedix's (CRMD) EV to EBIT was 2.04 for Q2 2026, down 86.2% from 14.77 a year earlier.

Analysis

CorMedix (CRMD) EV to EBIT (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, CorMedix's EV to EBIT came in at -0.25; for FY2025, it came in at 4.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CorMedix 609.51 Mn -43.01 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.04
Dec 31, 2025 5.08
Sep 30, 2025 8.22
Jun 30, 2025 14.77
Mar 31, 2025 23.46
API Access

CorMedix EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CRMD&period=max&api_key=YOUR_API_KEY